Allergy & Asthma Consultants
Redwood City, California, United States
Allergist in Redwood City, California
369 Main St #200, Redwood City, CA 94063
About Allergy & Asthma Consultants
"Welcome to Allergy and Asthma Consultants, the medical offices of Dr. Brian S. Lipson. We offer a wide range of treatment options for patients with allergic and asthmatic conditions. We are conveniently located in the Redwood City, Fremont, and Hayward communities to serve our patients across the San Francisco Bay Area."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Genentech, Inc.
3
Celldex Therapeutics
2
Eli Lilly and Company
1
Clinical Trials at Allergy & Asthma Consultants
During the past decade, Allergy & Asthma Consultants conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on
average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,068
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-08-31
2016-12-28
Completed
348
A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)
2013-06-19
2016-03-31
Completed
806
A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria
2015-05-18
2017-03-09
Completed
206
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
2016-09-20
2019-07-26
Completed
517
A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).
2017-05-26
2019-10-25
Completed
134
A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study
2018-09-27
2019-10-23
Terminated
31
A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria
2019-11-15
2021-02-24
Terminated
52
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Allergy & Asthma Consultants
According to Clinical.Site data, the most researched conditions in "Allergy & Asthma Consultants" are
"Asthma" (4 trials), "Urticaria" (3 trials), "Chronic Spontaneous Urticaria" (2 trials) and "Chronic Inducible Urticaria" (1 trials). Many other conditions were trialed in "Allergy & Asthma Consultants" in a lesser frequency.
Clinical Trials Intervention Types at Allergy & Asthma Consultants
Most popular intervention types in "Allergy & Asthma Consultants" are "Drug" (10 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "GDC-0853" (2 trials), "Lebrikizumab" (2 trials), "Matching Placebo" (2 trials) and "Omalizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Allergy & Asthma Consultants
The vast majority of trials in "Allergy & Asthma Consultants" are
10 trials for "All" genders.
Clinical Trials Status at Allergy & Asthma Consultants
Currently, there are NaN active trials in "Allergy & Asthma Consultants".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Allergy & Asthma Consultants,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Allergy & Asthma Consultants, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".